Cargando…
Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma.
Selective venous sampling catheterisation was performed in 19 patients with medullary thyroid carcinoma without known distant metastases for persistent hypercalcitoninaemia after surgery. Calcitonin (CT) gradients were found in the neck and/or the mediastinum in 18 patients and in five patients at d...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1969435/ https://www.ncbi.nlm.nih.gov/pubmed/8198983 |
_version_ | 1782134850549972992 |
---|---|
author | Abdelmoumene, N. Schlumberger, M. Gardet, P. Roche, A. Travagli, J. P. Francese, C. Parmentier, C. |
author_facet | Abdelmoumene, N. Schlumberger, M. Gardet, P. Roche, A. Travagli, J. P. Francese, C. Parmentier, C. |
author_sort | Abdelmoumene, N. |
collection | PubMed |
description | Selective venous sampling catheterisation was performed in 19 patients with medullary thyroid carcinoma without known distant metastases for persistent hypercalcitoninaemia after surgery. Calcitonin (CT) gradients were found in the neck and/or the mediastinum in 18 patients and in five patients at distant sites also. After venous catheterisation, 13 patients were subjected to repeat surgery. Neck and/or mediastinal tumour foci were found in 12 patients at the sites of the CT gradients. Of these, nine patients had only cervicomediastinal CT gradients: after reoperation, the serum CT level normalised in one, significantly decreased in five, and did not change in three, and no neck relapse occurred after a mean follow-up of 5.3 years. Distant metastases emerged clinically in all five patients with distant gradients and in only one of the 14 patients with no distant gradient. In conclusion, selective venous catheterisation is the most sensitive tool for the localisation of residual disease and for the early detection of distant metastases. However, in patients with only local disease, biochemical cure is rarely obtained after reoperation. |
format | Text |
id | pubmed-1969435 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1994 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-19694352009-09-10 Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma. Abdelmoumene, N. Schlumberger, M. Gardet, P. Roche, A. Travagli, J. P. Francese, C. Parmentier, C. Br J Cancer Research Article Selective venous sampling catheterisation was performed in 19 patients with medullary thyroid carcinoma without known distant metastases for persistent hypercalcitoninaemia after surgery. Calcitonin (CT) gradients were found in the neck and/or the mediastinum in 18 patients and in five patients at distant sites also. After venous catheterisation, 13 patients were subjected to repeat surgery. Neck and/or mediastinal tumour foci were found in 12 patients at the sites of the CT gradients. Of these, nine patients had only cervicomediastinal CT gradients: after reoperation, the serum CT level normalised in one, significantly decreased in five, and did not change in three, and no neck relapse occurred after a mean follow-up of 5.3 years. Distant metastases emerged clinically in all five patients with distant gradients and in only one of the 14 patients with no distant gradient. In conclusion, selective venous catheterisation is the most sensitive tool for the localisation of residual disease and for the early detection of distant metastases. However, in patients with only local disease, biochemical cure is rarely obtained after reoperation. Nature Publishing Group 1994-06 /pmc/articles/PMC1969435/ /pubmed/8198983 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Abdelmoumene, N. Schlumberger, M. Gardet, P. Roche, A. Travagli, J. P. Francese, C. Parmentier, C. Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma. |
title | Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma. |
title_full | Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma. |
title_fullStr | Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma. |
title_full_unstemmed | Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma. |
title_short | Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma. |
title_sort | selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1969435/ https://www.ncbi.nlm.nih.gov/pubmed/8198983 |
work_keys_str_mv | AT abdelmoumenen selectivevenoussamplingcatheterisationforlocalisationofpersistingmedullarythyroidcarcinoma AT schlumbergerm selectivevenoussamplingcatheterisationforlocalisationofpersistingmedullarythyroidcarcinoma AT gardetp selectivevenoussamplingcatheterisationforlocalisationofpersistingmedullarythyroidcarcinoma AT rochea selectivevenoussamplingcatheterisationforlocalisationofpersistingmedullarythyroidcarcinoma AT travaglijp selectivevenoussamplingcatheterisationforlocalisationofpersistingmedullarythyroidcarcinoma AT francesec selectivevenoussamplingcatheterisationforlocalisationofpersistingmedullarythyroidcarcinoma AT parmentierc selectivevenoussamplingcatheterisationforlocalisationofpersistingmedullarythyroidcarcinoma |